Subcutaneous testosterone-letrozole therapy before and concurrent with neoadjuvant breast chemotherapy: clinical response and therapeutic implications

OBJECTIVE: Hormone receptor-positive breast cancers respond favorably to subcutaneous testosterone combined with an aromatase inhibitor. However, the effect of testosterone combined with an aromatase inhibitor on tumor response to chemotherapy was unknown. This study investigated the effect of testo...

Descripción completa

Detalles Bibliográficos
Autores principales: Glaser, Rebecca L., York, Anne E., Dimitrakakis, Constantine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott-Raven Publishers 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636057/
https://www.ncbi.nlm.nih.gov/pubmed/28195993
http://dx.doi.org/10.1097/GME.0000000000000828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636057/
https://www.ncbi.nlm.nih.gov/pubmed/28195993
http://dx.doi.org/10.1097/GME.0000000000000828

Ejemplares similares